Mirova’s Organon & Co OGN Stock Holding History

Mirova’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-60,738	Closed	-$1.16M	–	132
2024 Q3	$1.16M	Hold	60,738	–	–	0.2%	65
2024 Q2	$1.26M	Buy	+60,738	New	+$1.21M	0.23%	65
2023 Q3	–	Sell	-473	Closed	-$9.84K	–	149
2023 Q2	$9.84K	Sell	473 -795	-63%	-$17.3K	﹤0.01%	163
2023 Q1	$29.8K	Buy	+1,268	New	+$34K	﹤0.01%	164
2021 Q4	–	Sell	-3,815	Closed	-$125K	–	200
2021 Q3	$125K	Buy	3,815 +437	+13%	+$14K	0.02%	159
2021 Q2	$102K	Buy	+3,378	New	+$111K	0.01%	160

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mirova's OGN Position: Q4 2024 in Review

Mirova sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 60,738 shares — an estimated $1.16M sold.

Mirova first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $1.26M in Q2 2024. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

Mirova reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
Mirova sold 60,738 Organon & Co shares in Q4 2024, an estimated $1.16M.
Mirova first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
Mirova's Organon & Co position peaked at $1.26M in Q2 2024.
740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Mirova's 13F filing for Q4 2024, filed 13 Feb 2025.